Literature DB >> 15758923

Peroral transgastric endoscopic ligation of fallopian tubes with long-term survival in a porcine model.

Sanjay B Jagannath1, Sergey V Kantsevoy, Cheryl A Vaughn, Sydney S C Chung, Peter B Cotton, Christopher J Gostout, Robert H Hawes, Pankaj J Pasricha, Diana G Scorpio, Carolyn A Magee, Laurie J Pipitone, Anthony N Kalloo.   

Abstract

BACKGROUND: We have previously reported the feasibility and safety of the peroral transgastric endoscopic approach for diagnostic peritoneoscopy, liver biopsy, and gastrojejunostomy with long-term survival in a porcine model. This approach eliminates incisions of the abdominal wall, providing a less invasive alternative to diagnostic and therapeutic laparoscopy. We now report successful performance of peroral endoscopic transgastric ligation of Fallopian tubes with long-term survival in a porcine model.
METHODS: Six female 50-kg pigs had general anesthesia and irrigation of the stomach with an antibiotic solution. Gastric puncture was performed with needleknife electrocautery followed by balloon dilatation of the tract with 20-mm TTS dilating balloon (Microvasive). A standard upper endoscope that underwent high-level disinfection and gas sterilzation was advanced into the peritoneal cavity through a sterile overtube. Both Fallopian tubes were identified and one was ligated using Olympus Endoloops. The other patent tube served as a control. Tubal patency was evaluated by hysterosalpingogram before and after ligation. After a follow-up period of 2-3 weeks, the pigs were sacrificed for postmortem examination.
RESULTS: The Fallopian tubes were easily accessed, identified and ligated in all 6 pigs. In each pig, fluoroscopy confirmed complete obstruction of the ligated tube with preserved patency of the other tube. All pigs survived well and ate heartily without any ill-effects. Postmortem examination did not reveal any peritonitis or intra-abdominal adhesions. The Endoloops were in place with complete obstruction of the ligated tubes and patency of the controls. Histopathologic examination of the tubes showed chronic inflammatory infiltrates without abscesses.
CONCLUSIONS: The peroral endoscopic transgastric approach to ligation of the Fallopian tubes with long-term survival is technically feasible and safe in a porcine model. The endoscopic transgastric approach to the peritoneal cavity has potential for a wide array of diagnostic and therapeutic procedures.

Entities:  

Mesh:

Year:  2005        PMID: 15758923     DOI: 10.1016/s0016-5107(04)02828-7

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  96 in total

1.  Transvaginal laparoscopically assisted endoscopic cholecystectomy: preliminary clinical results for a series of 43 cases in China.

Authors:  Jun Niu; Wei Song; Ming Yan; Wei Fan; Weibo Niu; Enyu Liu; Cheng Peng; Pengfei Lin; Peng Li; Abdul Qadir Khan
Journal:  Surg Endosc       Date:  2010-10-07       Impact factor: 4.584

2.  Hybrid natural orifice transluminal endoscopic cholecystectomy: prospective human series.

Authors:  Angel Cuadrado-Garcia; Jose F Noguera; Jose M Olea-Martinez; Rafael Morales; Carlos Dolz; Luis Lozano; Jose-Carlos Vicens; Juan José Pujol
Journal:  Surg Endosc       Date:  2010-06-10       Impact factor: 4.584

3.  Natural orifice transluminal endoscopic surgery: new minimally invasive surgery come of age.

Authors:  Chen Huang; Ren-Xiang Huang; Zheng-Jun Qiu
Journal:  World J Gastroenterol       Date:  2011-10-21       Impact factor: 5.742

4.  Pure natural orifice transluminal endoscopic surgery (NOTES) with ultrasonography-guided transgastric access and over-the-scope-clip closure: a porcine feasibility and survival study.

Authors:  Anders Meller Donatsky; Luise Andersen; Ole Lerberg Nielsen; Barbara Juliane Holzknecht; Peter Vilmann; Søren Meisner; Lars Nannestad Jørgensen; Jacob Rosenberg
Journal:  Surg Endosc       Date:  2012-01-12       Impact factor: 4.584

5.  Educational and training aspects of new surgical techniques: experience with the endoscopic–laparoscopic interdisciplinary training entity (ELITE) model in training for a natural orifice translumenal endoscopic surgery (NOTES) approach to appendectomy.

Authors:  Sonja Gillen; Jörn Gröne; Fritz Knödgen; Petra Wolf; Michael Meyer; Helmut Friess; Heinz-Johannes Buhr; Jörg-Peter Ritz; Hubertus Feussner; Kai S Lehmann
Journal:  Surg Endosc       Date:  2012-08       Impact factor: 4.584

6.  Efficacy and safety of transgastric closure in natural orifice transluminal endoscopic surgery using the OTSC system and T-bar sutures: a survival study in a porcine model.

Authors:  Abbas H Suhail; Ronald Mårvik; Jostein Halgunset; Esther Kuhry
Journal:  Surg Endosc       Date:  2012-05-02       Impact factor: 4.584

7.  NOTES, MANOS, SILS and other new laparoendoscopic techniques.

Authors:  José F Noguera; Angel Cuadrado
Journal:  World J Gastrointest Endosc       Date:  2012-06-16

8.  Evaluation of the clinical and inflammatory responses in exclusively NOTES transvaginal cholecystectomy versus laparoscopic routes: an experimental study in swine.

Authors:  Josiel P Vieira; Marcelo M Linhares; Elesiário M Caetano; Rita M A Moura; Vitor Asseituno; Rogério Fuzyi; Manoel J B Girão; José M Ruano; Alberto Goldenberg; Gaspar de Jesus L Filho; Délcio Matos
Journal:  Surg Endosc       Date:  2012-06-23       Impact factor: 4.584

Review 9.  Delayed assessment and eager adoption of laparoscopic cholecystectomy: implications for developing surgical technologies.

Authors:  Alexander C Allori; I Michael Leitman; Elizabeth Heitman
Journal:  World J Gastroenterol       Date:  2010-09-07       Impact factor: 5.742

10.  A 2-microm continuous-wave laser system for safe and high-precision dissection during NOTES procedures.

Authors:  Xavier Dray; Gianfranco Donatelli; Devi Mukkai Krishnamurty; Elena Dubcenco; Ronald J Wroblewski; Lia Assumpcao; Samuel A Giday; Jonathan M Buscaglia; Eun J Shin; Priscilla Magno; Laurie J Pipitone; Michael R Marohn; Sergey V Kantsevoy; Anthony N Kalloo
Journal:  Dig Dis Sci       Date:  2010-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.